Bankers Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
$979K Buy
20,189
+891
+5% +$43.9K 0.59% 64
2014
Q1
$1M Sell
19,298
-674
-3% -$35.9K 0.64% 60
2013
Q4
$1.06M Sell
19,972
-389
-2% -$19.8K 0.66% 62
2013
Q3
$942K Sell
20,361
-2,564
-11% -$113K 0.66% 66
2013
Q2
$1.02M Buy
+22,925
New +$995K 0.76% 56

Other funds holding BMY

Bankers Trust's BMY Position: Q2 2014 in Review

Bankers Trust increased its Bristol-Myers Squibb (BMY) stake by 4.6% in Q2 2014, buying an estimated $43.9K and bringing the position to 20,189 shares worth $979K. The position accounts for 0.59% of the portfolio, ranked #64.

Bankers Trust first reported a position in BMY in Q2 2013 and has held it in 5 quarters since. The position peaked at $1.06M in Q4 2013. 1,303 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

  • Bankers Trust held 20,189 shares of Bristol-Myers Squibb worth $979K as of Q2 2014.
  • Bankers Trust bought 891 Bristol-Myers Squibb shares in Q2 2014, an estimated $43.9K.
  • Bristol-Myers Squibb made up 0.59% of Bankers Trust's portfolio in Q2 2014, its #64 holding.
  • Bankers Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 5 quarters since.
  • Bankers Trust's Bristol-Myers Squibb position peaked at $1.06M in Q4 2013.
  • 1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Bankers Trust's 13F filing for Q2 2014, filed 15 Aug 2014.